Ulf Nehrbass
Vorstandsvorsitzender bei Luxembourg Institute of Health
Aktive Positionen von Ulf Nehrbass
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Luxembourg Institute of Health
Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Ulf Nehrbass
Ehemalige bekannte Positionen von Ulf Nehrbass
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
QURIENT CO., LTD. | Vorstandsvorsitzender | 12.08.2011 | - |
Statistik
International
Südkorea | 2 |
Luxemburg | 2 |
Operativ
Chief Executive Officer | 2 |
Sektoral
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
QURIENT CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Luxembourg Institute of Health
Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Commercial Services |
- Börse
- Insiders
- Ulf Nehrbass
- Erfahrung